HomeNewsBusinessMarketsGlenmark finds cancer drug, gains to reflect in long term

Glenmark finds cancer drug, gains to reflect in long term

Shares of Glenmark Pharmaceuticals rose nearly 2.5% on Thursday after the pharma giant announced discovery of a blood cancer drug GBR 401, which falls under biologic category of medicines. Athough discovery of the drug is a positive development, its impact on the company’s financials is a long term story, analysts said.

March 31, 2011 / 13:21 IST

Story continues below Advertisement

Shares of Glenmark Pharmaceuticals rose nearly 3% on Thursday after the pharma giant announced discovery of a blood cancer drug GBR 401, which falls under biologic category of medicines. Athough discovery of the drug is a positive development, its impact on the company

first published: Mar 31, 2011 11:48 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Download MC Apps:

Copyright © Network18 Media & Investments Limited. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Glenmark finds cancer drug, gains to reflect in long term

News

Features

Tools

Specials

Network 18 Sites

Personal Finance

Quick Links